Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Medicines Co. licenses potential anti-plaque drug from Pfizer in deal that could top $420M
Medicines Co. licenses potential anti-plaque drug from Pfizer in deal that could top $420M
Medicines Co. licenses potential anti-plaque drug from Pfizer in deal that could top $420M
Submitted by
admin
on December 23, 2009 - 8:25am
Source:
Yahoo/AP
News Tags:
Pfizer
Medicines Company
liscensing
ApoA-I Milano
Headline:
Medicines Co. licenses potential anti-plaque drug from Pfizer in deal that could top $420M
Do Not Allow Advertisers to Use My Personal information
